top of page
Browse by category
Search


Allurion to increase focus on low-dose GLP-1 combination therapy and muscle mass maintenance
Allurion Technologies has revealed a strategic direction with an increasing focus on low-dose GLP-1 combination therapy, muscle mass...


Journal Watch 6/8/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


NICE: People need support to keep weight off after treatment ends
The National Institute for Health and Care Excellence in the UK has stated that people coming off obesity medication or finishing a...


Saliva testing may reveal early signs of metabolic disease
The University of British Columbia (UBC) Okanagan team has found that measuring insulin levels in saliva offers a non-invasive way...


Systematic review highlights micronutrient deficiencies after bariatric surgery
A systematic review of case reports on late micronutrient deficiencies after bariatric surgery highlights the wide range of deficiencies...


Five-year outcomes reveal RefluxStop surgery can offer sustained safe and effective relief from GERD
The five-year outcomes from a prospective, single-arm, multi-centre clinical study investigating RefluxStop surgery, has revealed the...


Biofragmentable magnetic anastomosis system is feasible, safe and effective in achieving incisionless, suture- or staple-free MagDI bipartition
Researchers from Canada and the Republic of Georgia have found the swallowable, biofragmentable magnetic anastomosis system (BMAS) was...


Journal Watch 30/7/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Gut microbe byproducts may help restore critical hormone-producing cells in the intestine
Scientists at the Marshall University Joan C Edwards School of Medicine have reported that certain gut microbial by-products may hold...


Positive results for Apnimed’s AD109 for treating obstructive sleep apnoea
Apnimed has announced positive topline results from its second pivotal Phase 3 clinical trial – LunAIRo - of Apnimed's lead candidate...
Browse by tag






bottom of page
